Rigel reports Q4 revenue of $69.8 million, projects 2026 growth
Go back to Rigel reports Q4 revenue of $69.8 million, projects 2026 growth| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 30.25 -0.05 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.30 | 52 Week High | $4.38 | |||
| Open | $30.56 | 52 Week Low | $1.88 | |||
| Day High | $31.09 | P/E | N/A | |||
| Day Low | $30.23 | EPS | $-1.12 | |||
| Volume | 64,440 | |||||
